Literature DB >> 20467898

Diabetes mellitus increases the risk of mortality following liver transplantation independent of MELD score.

Andrew L Samuelson1, Maximilian Lee, Ahmad Kamal, Emmet B Keeffe, Aijaz Ahmed.   

Abstract

BACKGROUND: Patients with diabetes mellitus overall experience worse health outcomes than non-diabetics, but whether this is true among recipients of liver transplantation still remains unclear. The aim of this study was to compare the mortality of diabetic and non-diabetic patients following liver transplantation.
METHODS: We conducted a retrospective analysis of 530 adult patients undergoing liver transplantation at Stanford University Medical Center from February 1995 to July 2006. Information on diabetes mellitus was available for 431 patients; 96 patients who had acute liver failure (n = 17), combined liver and kidney transplantation (n = 28), or died prior to discharge (n = 51) were excluded from analysis.
RESULTS: Over a mean follow-up of 4.5 years, survival was 81% in the diabetic group and 94% among controls (p = <0.0001). After controlling for age (mean +/- SD: 54.4 +/- 7.6 in diabetics, 50.1 +/- 9.6 in controls), body mass index (28.6 +/- 6.6 in diabetics, 27.1 +/- 5.4 in controls), presence of hepatitis C, and MELD score (17 +/- 9.6 in diabetics, 19 +/- 10.2 in controls), diabetes mellitus remained a significant predictor of death (HR 3.11, p = 0.01).
CONCLUSIONS: Diabetes mellitus is an independent risk factor for mortality following liver transplantation. Further investigation of this relationship should focus on the impact of more intensive pre- and post-liver transplantation glucose control, cardiovascular risk factor reduction, and the effects of accelerated atherosclerosis in the setting of immune suppression.

Entities:  

Mesh:

Year:  2010        PMID: 20467898     DOI: 10.1007/s10620-010-1267-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

1.  Causes of death after liver transplantation in 4000 consecutive patients: 2 to 19 year follow-up.

Authors:  R Kashyap; A Jain; J Reyes; A J Demetris; K A Elmagd; S F Dodson; W Marsh; V Madariaga; G Mazariegos; D Geller; C A Bonham; T Cacciarelli; P Fontes; T E Starzl; J J Fung
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

Review 2.  The global spread of type 2 diabetes mellitus in children and adolescents.

Authors:  Orit Pinhas-Hamiel; Philip Zeitler
Journal:  J Pediatr       Date:  2005-05       Impact factor: 4.406

3.  Survival after liver transplantation in diabetics.

Authors:  H E Wahlstrom; J Cooper; G Gores; C Rosen; R Wiesner; R A Krom
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

4.  Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States.

Authors:  Satheesh Nair; Sumita Verma; Paul J Thuluvath
Journal:  Hepatology       Date:  2002-01       Impact factor: 17.425

Review 5.  Risk for posttransplant Diabetes mellitus with current immunosuppressive medications.

Authors:  M R Weir; J C Fink
Journal:  Am J Kidney Dis       Date:  1999-07       Impact factor: 8.860

6.  Outcome of liver transplantation in patients with diabetes mellitus: a case-control study.

Authors:  P R John; P J Thuluvath
Journal:  Hepatology       Date:  2001-11       Impact factor: 17.425

7.  MELD and other factors associated with survival after liver transplantation.

Authors:  K V Narayanan Menon; Scott L Nyberg; William S Harmsen; Nelson F DeSouza; Charles B Rosen; Ruud A F Krom; Russell H Wiesner
Journal:  Am J Transplant       Date:  2004-05       Impact factor: 8.086

8.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

9.  The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation.

Authors:  Hwan Y Yoo; Paul J Thuluvath
Journal:  Transplantation       Date:  2002-10-15       Impact factor: 4.939

10.  Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis.

Authors:  A S Petrides; C Vogt; D Schulze-Berge; D Matthews; G Strohmeyer
Journal:  Hepatology       Date:  1994-03       Impact factor: 17.425

View more
  17 in total

1.  Association between E23K variant in KCNJ11 gene and new-onset diabetes after liver transplantation.

Authors:  Zahra Parvizi; Negar Azarpira; Leila Kohan; Masumeh Darai; Kourosh Kazemi; Mohamad Mehdi Parvizi
Journal:  Mol Biol Rep       Date:  2014-07-05       Impact factor: 2.316

2.  Pretransplant diabetes mellitus predicts worse outcomes of liver transplantation: evidence from meta-analysis.

Authors:  P Li; H Fan; Q He
Journal:  J Endocrinol Invest       Date:  2017-06-30       Impact factor: 4.256

Review 3.  The role of lifestyle changes in the management of chronic liver disease.

Authors:  Valerio Nobili; Christine Carter-Kent; Ariel E Feldstein
Journal:  BMC Med       Date:  2011-06-06       Impact factor: 8.775

4.  Intensified blood glucose treatment in diabetic patients undergoing a liver transplant: impact on graft evolution at 3 months and at 5 years.

Authors:  A Ramos-Prol; D Hervás-Marín; B Rodríguez-Medina; M Rubio-Almanza; M Berenguer; Á Moya-Herraiz; J F Merino-Torres
Journal:  J Endocrinol Invest       Date:  2017-12-30       Impact factor: 4.256

5.  Impact of preexisting diabetes mellitus on outcome after liver transplantation in patients with hepatitis B virus-related liver disease.

Authors:  Qi Ling; Xiao Xu; Qiang Wei; Xuyong Wei; Zhuoyi Wang; Lin Zhou; Shusen Zheng
Journal:  Dig Dis Sci       Date:  2010-08-12       Impact factor: 3.199

Review 6.  Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS.

Authors:  Mohamad R Al Sibae; Mitchell S Cappell
Journal:  Dig Dis Sci       Date:  2010-09-16       Impact factor: 3.199

7.  Diabetes, body mass index, and outcomes in hepatocellular carcinoma patients undergoing liver transplantation.

Authors:  Abby B Siegel; Emerson A Lim; Shuang Wang; William Brubaker; Rosa D Rodriguez; Abhishek Goyal; Judith S Jacobson; Dawn L Hershman; Elizabeth C Verna; Jonah Zaretsky; Karim Halazun; Lorna Dove; Robert S Brown; Alfred I Neugut; Tomoaki Kato; Helen Remotti; Yael J Coppleson; Jean C Emond
Journal:  Transplantation       Date:  2012-09-15       Impact factor: 4.939

8.  Metabolic syndrome after liver transplantation: preventable illness or common consequence?

Authors:  Eric R Kallwitz
Journal:  World J Gastroenterol       Date:  2012-07-28       Impact factor: 5.742

9.  Hyperglycemia and liver ischemia reperfusion injury: a role for the advanced glycation endproduct and its receptor pathway.

Authors:  S Yue; H M Zhou; J J Zhu; J H Rao; R W Busuttil; J W Kupiec-Weglinski; L Lu; Y Zhai
Journal:  Am J Transplant       Date:  2015-06-25       Impact factor: 9.369

10.  Liver grafts for transplantation from donors with diabetes: an analysis of the Scientific Registry of Transplant Recipients database.

Authors:  Jun Zheng; Jie Xiang; Jie Zhou; Zhiwei Li; Zhenhua Hu; Chung Mau Lo; Weilin Wang
Journal:  PLoS One       Date:  2014-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.